EU clears Elanco/Bayer with pipeline product divestments

The European Commission has approved Elanco’s $7.6 billion purchase of Bayer’s animal health business, subject to the divestment of existing and pipeline products in the pet and livestock pharmaceutical markets.

Get unlimited access to all Global Competition Review content